Single-center risk factor analysis for FOLFIRINOX associated febrile neutropenia in patients with pancreatic cancer
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Keum, Jiyoung | - |
dc.contributor.author | Lee, Hee Seung | - |
dc.contributor.author | Kang, Huapyong | - |
dc.contributor.author | Jo, Jung Hyun | - |
dc.contributor.author | Chung, Moon Jae | - |
dc.contributor.author | Park, Jeong Youp | - |
dc.contributor.author | Park, Seung Woo | - |
dc.contributor.author | Song, Si Young | - |
dc.contributor.author | Bang, Seungmin | - |
dc.date.available | 2021-03-05T06:40:05Z | - |
dc.date.created | 2021-03-05 | - |
dc.date.issued | 2020-04 | - |
dc.identifier.issn | 0344-5704 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/80275 | - |
dc.description.abstract | Purpose FOLFIRINOX is the standard therapy in patients with unresectable pancreatic cancer (PC). However, FOLFIRINOX frequently induces febrile neutropenia (FN) and neutropenia. The purpose of this study was to explore risk factors for FN and grade 4 neutropenia (NP G4) in patients receiving FOLFIRINOX for PC. Methods We collected data on 106 patients with PC treated with first-line FOLFIRINOX between 2015 and 2017 using the Pancreatic Cancer Cohort Registry of Severance Hospital in Seoul, Korea. Results Multivariate logistic regression analysis showed that female (OR, 3.24; P = 0.023), Eastern Cooperative Oncology Group performance status (OR, 3.70; P = 0.024), overweight (OR, 4.25; P = 0.022), and initial biliary stent insertion (OR, 4.22; P = 0.008) were significantly related to a high risk of FN. Time-dependent bias was reduced using Cox regression analysis, which revealed that female (OR, 2.29; P = 0.041), overweight (OR, 2.67; P = 0.022), and initial biliary stent insertion (OR, 2.59; P = 0.016) were statistically significant predictors. Regarding NP G4, female sex (OR, 2.90; P = 0.016) and overweight (OR, 4.07; P = 0.033) were identified as risk factors in multivariate analysis; however, in Cox regression analysis, tumor in the head of the pancreas (OR, 1.96; P = 0.027) and hemoglobin (g/dL < 12) (OR, 1.87; P = 0.049) were also identified as risk factors. Conclusion Female sex, overweight, and initial biliary stent insertion were independent risk factors for the occurrence of FN in patients with unresectable PC treated with FOLFIRINOX. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | SPRINGER | - |
dc.relation.isPartOf | CANCER CHEMOTHERAPY AND PHARMACOLOGY | - |
dc.title | Single-center risk factor analysis for FOLFIRINOX associated febrile neutropenia in patients with pancreatic cancer | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000520641000002 | - |
dc.identifier.doi | 10.1007/s00280-020-04051-x | - |
dc.identifier.bibliographicCitation | CANCER CHEMOTHERAPY AND PHARMACOLOGY, v.85, no.4, pp.651 - 659 | - |
dc.description.isOpenAccess | N | - |
dc.citation.endPage | 659 | - |
dc.citation.startPage | 651 | - |
dc.citation.title | CANCER CHEMOTHERAPY AND PHARMACOLOGY | - |
dc.citation.volume | 85 | - |
dc.citation.number | 4 | - |
dc.contributor.affiliatedAuthor | Kang, Huapyong | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | Pancreatic cancer | - |
dc.subject.keywordAuthor | Chemotherapy | - |
dc.subject.keywordAuthor | Neutropenia | - |
dc.subject.keywordAuthor | Febrile neutropenia | - |
dc.subject.keywordPlus | BODY-SURFACE AREA | - |
dc.subject.keywordPlus | SKELETAL-MUSCLE | - |
dc.subject.keywordPlus | CHEMOTHERAPY | - |
dc.subject.keywordPlus | DETERMINANT | - |
dc.subject.keywordPlus | TOXICITY | - |
dc.subject.keywordPlus | GEMCITABINE | - |
dc.subject.keywordPlus | EFFICACY | - |
dc.subject.keywordPlus | AGENTS | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.